Related Experiment Video
Updated: Aug 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Novel slow-skeletal myosin (MYH7) mutation in the original myosin storage myopathy kindred
Danielle E Dye1, Biagio Azzarelli, Hans H Goebel
1Molecular Neurogenetics Laboratory, Centre for Medical Research, West Australian Institute for Medical Research, University of Western Australia M519, 'B' Block, Queen Elizabeth II Medical Centre, Nedlands, WA 6009, Australia.
Abstract:
Myosin storage myopathy (OMIM 608358), a congenital myopathy characterised by subsarcolemmal, hyaline-like accumulations of myosin in Type I muscle fibres, was first described by Cancilla and Colleagues in 1971 [Neurology 1971;21:579-585] in two siblings as 'familial myopathy with probable lysis of myofibrils in type I muscle fibres'. Two mutations in the slow skeletal myosin heavy chain gene (MYH7) have recently been associated with the disease in other families. We have identified a novel heterozygous Leu1793Pro mutation in MYH7 in DNA from paraffin sections of one of the original siblings. This historical molecular analysis confirms the original cases had myosin storage myopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Overview of Myosin Structure and Function
Satellite Stem Cells and Muscular Dystrophy
Alterations in Muscle Tone lll
Huntington Disease l: Introduction
Lysosomal Hydrolases

